Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I

Involvement of WNT/β-catenin Signaling in the Treatment of Osteoporosis

(2013) Maurizio Rossini et al.   CALCIFIED TISSUE INTERNATIONAL

Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab

(2012) Davide Gatti et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin

(2011) Davide Gatti et al.   BONE

The Waning of Teriparatide Effect on Bone Formation Markers in Postmenopausal Osteoporosis Is Associated with Increasing Serum Levels of DKK1

(2011) Davide Gatti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

New perspectives on osteogenesis imperfecta

(2011) Antonella Forlino et al.   Nature Reviews Endocrinology

Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis

(2010) Joel S. Finkelstein et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Osteogenesis Imperfecta: Update on presentation and management

(2008) Moira S. Cheung et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis

(2007) Steven Boonen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM